SE-Asian Healthcare & Pharma Show

Exhibition time: April 23-25, 2025

Economics & Demographics

  • Economics & Demographics
  • The population in 2020 was 32.7 million
  • The population aged 65 and over accounted for about 7% of the total population in 2020 and is expected to age by 2030
  • Obesity and diabetes are of particular concern, with Malaysia ranked 6th in the Asia-Pacific region for obesity and diabetes and 1st in Southeast Asia in 2019. According to the data, it is estimated that 7 million adults in Malaysia will be affected by diabetes by 2025
  • According to the International Monetary Fund, gross domestic product (GDP) growth is expected to be 7.8% in 2021 and 5% in 2025

Overview of the medical device market

  • Malaysia’s domestic medical device market was approximately US$2 billion in 2022, growing at a compound annual growth rate (CAGR) of 7.5% from 2018 to 2022.
  • Malaysian medical manufacturer exports to supply 60% of the world’s medical glove market and 80% of the catheter market.
  • In terms of domestic medical device consumption, about 95% of Malaysia’s current medical device demand comes from imports.
  • Considering the robustness of the regulatory network, the application of digital distribution and the centralization of the procurement process for medical device companies entering the Malaysian market, it has high market appeal.
  • Malaysia has attracted some notable multinational companies, including B. Braun, which has its Asia-Pacific headquarters in Penang, Malaysia.
  • The medical device industry is expected to have a positive impact on Malaysia’s economy as the medical device industry shifts to manufacturing higher value-added and technologically advanced products such as heart rhythm devices, stents, orthopedic implants, e-medical, therapeutic, and monitoring devices.

Health care system

  • Malaysia has a two-tier healthcare system: a government-based universal healthcare system, an efficient private healthcare system (fully self-funded and/or privately insured). The government allocated $7 billion to the public healthcare sector in 2019, up 7.8 percent from 2018 and almost 10 percent of the state budget.
  • Due to the moderate GDP per capita, the demand for private healthcare services in Malaysia is expected to continue to grow beyond the current demand, mainly from the upper middle income to the affluent.
  • According to Dezan Shira and Associates, the healthcare industry is expected to grow to $30 billion by 2027 due to an aging population, rising wealth, and increased life expectancy.
  • Malaysia has some of the lowest healthcare costs in the world (about 40% lower than the US and UK), with the government subsidizing up to 98% of healthcare costs.
  • Despite stiff competition from more established neighbours Singapore and Thailand, Malaysia is also considered a potential hub for medical services in Southeast Asia.

Venue: MITEC, Kuala Lumpur, Malaysia
Exhibition time: April 23-25, 2025
ESPO subsidy code: MYI0212800

For more information about the exhibition and registration, please submit the form below

Scroll to Top